• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估接受戒断治疗的酒精使用障碍患者中的磷脂酰乙醇消除情况。

Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment.

机构信息

Institute of Forensic Medicine, Forensic Toxicology and Chemistry, University of Bern, Murtenstrasse 26, 3008 Bern, Switzerland.

Graduate School for Cellular and Biomedical Sciences, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland.

出版信息

Alcohol Alcohol. 2023 May 9;58(3):266-273. doi: 10.1093/alcalc/agad010.

DOI:10.1093/alcalc/agad010
PMID:36892399
Abstract

AIMS

Phosphatidylethanol (PEth) is used to monitor alcohol consumption in alcohol use disorder (AUD). In this study, we aim to evaluate the elimination time of PEth with regard to the clinically established 200 and 20 ng/ml cutoffs for PEth 16:0/18:1.

METHODS

Data from 49 patients undergoing treatment for AUD were evaluated. PEth concentrations were measured at the beginning and repeatedly during the treatment period of up to 12 weeks to monitor the elimination of PEth. We evaluated the time in weeks until the cutoff concentrations of <200 and <20 ng/ml were achieved. The correlation between the initial PEth concentration and the number of days until the PEth concentration had dropped below 200 and 20 ng/ml was assessed by calculating Pearson's correlation coefficients.

RESULTS

The initial PEth concentrations ranged from <20 to >2500 ng/ml. In 31 patients, the time until the cutoff values were reached could be documented. Even after 6 weeks of abstinence, PEth concentrations above the cutoff of 200 ng/ml could still be detected in two patients. A strong significant positive correlation was found between the initial PEth concentration and the time required to drop below the two cutoffs.

CONCLUSION

A waiting period of more than 6 weeks after declared abstinence should be granted for individuals with AUD before using only one single PEth concentration to assess the consumption behavior. However, we recommend to always use at least two PEth concentrations for the evaluation of alcohol-drinking behaviors in AUD patients.

摘要

目的

磷脂酰乙醇(PEth)用于监测酒精使用障碍(AUD)患者的饮酒量。本研究旨在评估 PEth 的消除时间,以达到临床上确立的 200 和 20ng/ml 的 PEth16:0/18:1 截止值。

方法

评估 49 名接受 AUD 治疗患者的数据。在治疗期间,我们多次测量 PEth 浓度,以监测 PEth 的消除情况,最长可达 12 周。我们评估了达到<200 和<20ng/ml 截止值所需的周数。通过计算 Pearson 相关系数评估初始 PEth 浓度与达到低于 200 和 20ng/ml 的 PEth 浓度的天数之间的相关性。

结果

初始 PEth 浓度范围从<20 到>2500ng/ml。在 31 名患者中,可以记录达到截止值的时间。即使在 6 周的禁欲后,仍有两名患者的 PEth 浓度仍高于 200ng/ml 的截止值。初始 PEth 浓度与达到两个截止值所需的时间之间存在很强的正相关关系。

结论

在 AUD 患者仅使用单个 PEth 浓度评估其饮酒行为之前,应给予宣告禁欲后超过 6 周的等待期。然而,我们建议在评估 AUD 患者的饮酒行为时,始终使用至少两个 PEth 浓度。

相似文献

1
Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment.评估接受戒断治疗的酒精使用障碍患者中的磷脂酰乙醇消除情况。
Alcohol Alcohol. 2023 May 9;58(3):266-273. doi: 10.1093/alcalc/agad010.
2
Can PEth be Detected with a Cutoff of 20 ng/mL after Single Alcohol Consumption?单次饮酒后,PEth 的检测截断值能否设定为 20ng/mL?
J Anal Toxicol. 2023 Jan 24;46(9):e232-e238. doi: 10.1093/jat/bkac069.
3
Alcohol Biomarker Phosphatidylethanol as a Predictor of the Severity of Alcohol Withdrawal Syndrome.酒精生物标志物磷脂酰乙醇作为酒精戒断综合征严重程度的预测指标。
Alcohol Alcohol. 2023 Mar 10;58(2):198-202. doi: 10.1093/alcalc/agac071.
4
Phosphatidylethanol (PEth) detected in blood for 3 to 12 days after single consumption of alcohol-a drinking study with 16 volunteers.单次饮酒后3至12天在血液中检测到磷脂酰乙醇(PEth)——一项针对16名志愿者的饮酒研究。
Int J Legal Med. 2017 Jan;131(1):153-160. doi: 10.1007/s00414-016-1445-x. Epub 2016 Sep 5.
5
The roles of phosphatidylethanol, ethyl glucuronide, and ethyl sulfate in identifying alcohol consumption among participants in professionals health programs.磷脂酰乙醇、乙基葡萄糖醛酸苷和乙基硫酸酯在鉴定参与专业人员健康计划者的饮酒情况中的作用。
Drug Test Anal. 2020 Aug;12(8):1102-1108. doi: 10.1002/dta.2809. Epub 2020 Jul 3.
6
PEth 16:0/18:1 and 16:0/18:2 after consumption of low doses of alcohol-A contribution to cutoff discussion.饮酒低剂量后 PEth 16:0/18:1 和 16:0/18:2-对截止值讨论的贡献。
Drug Test Anal. 2023 Jan;15(1):104-114. doi: 10.1002/dta.3376. Epub 2022 Oct 18.
7
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial.基于生物标志物磷脂酰乙醇(PEth)16:0/18:1 检测的远程医疗应急管理干预用于治疗酒精使用障碍的可行性:一项先导随机试验。
Am J Drug Alcohol Abuse. 2024 Mar 3;50(2):162-172. doi: 10.1080/00952990.2023.2283691. Epub 2024 Jan 29.
8
Validating Self-Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV.验证 HIV 患者自我报告的不健康酒精使用与磷脂酰乙醇(PEth)的相关性。
Alcohol Clin Exp Res. 2020 Oct;44(10):2053-2063. doi: 10.1111/acer.14435. Epub 2020 Sep 19.
9
Set-up of a population-based model to verify alcohol abstinence via monitoring of the direct alcohol marker phosphatidylethanol 16:0/18:1.建立基于人群的模型,通过监测直接酒精标志物磷脂酰乙醇16:0/18:1来验证戒酒情况。
Addiction. 2022 Jul;117(7):2108-2118. doi: 10.1111/add.15811. Epub 2022 Feb 13.
10
Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test - C (AUDIT-C).与酒精使用障碍识别测试-C(AUDIT-C)相比,评估反映不同饮酒习惯的磷脂酰乙醇(PEth)水平。
Drug Alcohol Depend. 2017 Sep 1;178:80-86. doi: 10.1016/j.drugalcdep.2017.04.026. Epub 2017 Jun 13.

引用本文的文献

1
Utilising paired measurements of phosphatidylethanol to monitor early success in alcohol abstinence.利用磷脂酰乙醇的配对测量来监测戒酒早期的成功情况。
Drug Alcohol Rev. 2025 Jan;44(1):80-89. doi: 10.1111/dar.13947. Epub 2024 Sep 16.
2
Interlaboratory comparison of phosphatidylethanol in dried blood spots using different sampling devices.使用不同采样设备对干血斑中磷脂酰乙醇进行实验室间比对
Drug Test Anal. 2025 Jun;17(6):834-841. doi: 10.1002/dta.3784. Epub 2024 Aug 16.